Catalyst Pharmaceuticals Ownership | Who Owns Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals Ownership Summary
Catalyst Pharmaceuticals is owned by 80.20% institutional investors, 6.28% insiders, and 13.53% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 16.33% of CPRX shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.58% of its assets in Catalyst Pharmaceuticals shares.
CPRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Catalyst Pharmaceuticals | 80.20% | 6.28% | 13.53% |
| Sector | Healthcare Stocks | 279.15% | 10.63% | -189.78% |
| Industry | Biotech Stocks | 63.94% | 10.67% | 25.38% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 19.43M | 16.33% | $405.40M |
| Blackrock | 18.69M | 16.01% | $289.58M |
| Vanguard group | 8.43M | 7.09% | $175.96M |
| State street | 5.80M | 4.87% | $120.97M |
| Deerfield management company, l.p. (series c) | 3.13M | 2.63% | $65.39M |
| Dimensional fund advisors lp | 3.01M | 2.53% | $62.88M |
| Pacer advisors | 2.96M | 2.49% | $61.68M |
| Goldman sachs group | 2.80M | 2.36% | $58.49M |
| Renaissance | 2.71M | 2.28% | $56.48M |
| Geode capital management | 2.67M | 2.24% | $55.64M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Tanaka capital management | 153.29K | 7.31% | $3.20M |
| Gables capital management | 417.55K | 4.20% | $8.71M |
| Jw asset management | 413.39K | 4.10% | $8.63M |
| Qsv equity investors | 84.06K | 1.69% | $1.75M |
| Knott david m jr | 210.00K | 1.58% | $4.38M |
| Resolute capital asset partners | 137.50K | 1.54% | $2.87M |
| Deerfield management company, l.p. (series c) | 3.13M | 1.24% | $65.39M |
| Mesirow institutional investment management | 742.29K | 1.19% | $15.49M |
| Ikarian capital | 349.65K | 0.99% | $7.30M |
| Moody aldrich partners | 215.66K | 0.83% | $4.50M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Goldman sachs group | 2.80M | 0.01% | 1.33M |
| Blackrock | 18.69M | 0.01% | 962.28K |
| Macquarie group | 682.65K | 0.02% | 682.65K |
| Ubs group | 722.86K | 0.00% | 510.01K |
| Abrdn | 484.67K | 0.02% | 484.67K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deerfield management company, l.p. (series c) | 3.13M | 1.24% | -3.10M |
| Morgan stanley | 1.01M | 0.00% | -786.18K |
| Point72 asset management | - | - | -618.30K |
| Brandywine global investment management | - | - | -392.12K |
| Deutsche bank ag\ | 200.40K | 0.00% | -377.81K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Macquarie group | 682.65K | 0.02% | 682.65K | $14.25M |
| Abrdn | 484.67K | 0.02% | 484.67K | $10.11M |
| Raymond james financial | 329.98K | 0.00% | 329.98K | $6.89M |
| Clark capital management group | 207.73K | 0.03% | 207.73K | $4.34M |
| Renaissance group | 202.76K | 0.18% | 202.76K | $4.23M |
Sold Out
| Holder | Change |
|---|---|
| Global financial private client | -1.00 |
| Coppell advisory solutions | -8.00 |
| Mendota financial group | -12.00 |
| Richards, merrill & peterson | -15.00 |
| Aspire private capital | -20.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 361 | 6.80% | 97,419,101 | -0.16% | 80 | 1.19% | 193 | -4.46% | 119 | 33.71% |
| Dec 31, 2024 | 329 | 4.44% | 99,023,975 | 3.92% | 83 | 1.30% | 195 | 21.88% | 87 | -17.14% |
| Sep 30, 2024 | 313 | 14.65% | 95,228,606 | -1.82% | 80 | 1.16% | 159 | 25.20% | 104 | 18.18% |
| Jun 30, 2024 | 270 | - | 96,978,188 | 0.88% | 83 | 1.02% | 126 | -20.75% | 87 | 26.09% |
| Mar 31, 2024 | 270 | 4.25% | 96,131,186 | 13.87% | 90 | 1.44% | 159 | 39.47% | 69 | -25.81% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 6.81M | 5.58% | -19.04K |
| Vanguard Total Stock Mkt Idx Inv | 3.69M | 3.03% | 3.10K |
| Vanguard US Total Market Shares ETF | 3.55M | 2.91% | 3.78K |
| iShares Russell 2000 ETF | 2.90M | 2.37% | 20.13K |
| First Trust NYSE Arca Biotech ETF | 1.89M | 1.59% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.74M | 1.43% | 12.01K |
| Avantis US Small Cap Value ETF | 1.23M | 1.01% | 10.15K |
| SPDR® S&P Biotech ETF | 1.17M | 0.96% | -19.11K |
| Fidelity Small Cap Index | 1.14M | 0.94% | 13.36K |
| iShares Russell 2000 Growth ETF | 1.02M | 0.83% | 2.51K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 11, 2025 | Sundaram Preethi | Chief Strategy Officer | Sell | $42.27K |
| Jun 10, 2025 | Sundaram Preethi | Chief Strategy Officer | Sell | $61.38K |
| Jun 09, 2025 | MCENANY PATRICK J | Chairman of Board of Directors | Sell | $4.48M |
| Jun 06, 2025 | MCENANY PATRICK J | Chairman of Board of Directors | Sell | $733.00K |
| May 30, 2025 | Daly Richard J | President and CEO | Buy | $1.74M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | 7 |
| 2025 Q1 | - | 5 |
| 2024 Q4 | - | 14 |
| 2024 Q3 | - | 7 |
| 2024 Q2 | - | 5 |
CPRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools